Implementation of a Delirium Screening

Not Applicable

Withdrawn

• Conditions: Bone Marrow Ablation; Delirium; Cancer
• Interventions: Behavioral: Delirium Screen

• Registration Number: NCT03360474
• Lead Sponsor: University of Miami

Brief Summary

The purpose of this project is to improve patient outcomes in individuals affected by cancer, through the implementation of a delirium screening and treatment protocol in the ICU setting. The hypothesis is that patients who receive an accurate and early diagnosis of delirium coupled with a standardized intervention protocol will demonstrate improved patient outcomes as evidenced by fewer days spent in the ICU, fewer days spent in the hospital (overall length of stay) and the need for less sedative medication throughout their ICU stay as compared to patient data prior to the implementation of a delirium protocol.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design

Study Timeline

• Status Verified: 2017-11
• Study First Submitted: 2017-11-17
• Study First Submitted QC: 2017-11-27
• Study First Posted: 2017-12-04
• Last Update Submitted: 2018-05-29
• Last Update Posted: 2018-05-31
• Study Start: 2018-06
• Primary Completion: 2018-08
• Study Completion: 2018-12

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Patients will be included into the study who:

  • Are over 18 years old
  • Speak and read English
  • Are admitted to the Sylvester Comprehensive Cancer Center intensive care unit in the first 60 days following implementation of the delirium protocol; approximately 10 patients per month.
  • Patient data via electronic medical record (EMR) for all patients who were admitted to the Sylvester Comprehensive Cancer Center intensive care unit up to 60 days prior to the implementation of the delirium protocol.

Read More

Exclusion Criteria

• This study will exclude:

  • Patients who are unable to speak and read English
  • Patients who are unable to provide written consent to participate.
  • Patient data via EMR for any patients who were admitted to the Sylvester Comprehensive Cancer Center intensive care unit prior to 60 days before to the implementation of the delirium protocol.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Intervention	Delirium Screen	Patients will be placed on the delirium screening intervention protocol arm. They will be screened for delirium twice per day. If positive, they will follow the treatment algorithm and assessed at 4 hour intervals until they reach 4 negative screens. Once 4 negative screens have been reached, they will be assessed twice daily.

Primary Outcome Measures

Name	Time	Method
ICU Length of Stay (LOS)	60 days	Patient's length of stay in the ICU

Secondary Outcome Measures

Name	Time	Method
Overall LOS in hospital	60 days	Patient's length of stay in hospital
Sedation Medication	60 days	Total amount of sedating medication given to patient during their hospitalization.